Carmignac Portfolio Emerging Discovery A EUR AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 5.5 | 17.8 | -18.0 | 10.0 | 20.6 | |
+/-Cat | -7.3 | 2.8 | -7.2 | -2.6 | 15.3 | |
+/-B’mrk | -8.2 | 9.0 | -11.7 | 0.5 | 13.5 | |
Category: Global Emerging Markets Small/Mid-Cap Equity | ||||||
Category Benchmark: Morningstar EM SMID TME NR USD |
Key Stats | ||
NAV 20/11/2024 | EUR 2058.35 | |
Day Change | -0.08% | |
Morningstar Category™ | Global Emerging Markets Small/Mid-Cap Equity | |
ISIN | LU0336083810 | |
Fund Size (Mil) 20/11/2024 | EUR 128.30 | |
Share Class Size (Mil) 20/11/2024 | EUR 69.41 | |
Max Initial Charge | 4.00% | |
Ongoing Charge 16/02/2024 | 2.30% |
Investment Objective: Carmignac Portfolio Emerging Discovery A EUR Acc |
The Sub-Fund’s objective is to outperform its reference indicator over a recommended investment horizon of five years. This Sub-Fund is an actively managed UCITS. The investment manager has discretion over the composition of its portfolio, subject to the stated investment objectives and policy. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Amol Gogate 01/02/2021 | ||
Xavier Hovasse 01/01/2011 | ||
Inception Date 14/12/2007 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
50% MSCI EM Small NR USD , 50% MSCI EM Mid NR USD | Morningstar EM SMID TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Carmignac Portfolio Emerging Discovery A EUR Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Waaree Energies Ltd | Technology | 4.04 |
Max Healthcare Institute Ltd Ord... | Healthcare | 3.26 |
Asia Commercial Joint Stock Bank... | Financial Services | 3.06 |
PT Cisarua Mountain Dairy Tbk | Consumer Defensive | 2.57 |
Msci China Futur | 2.55 | |
Increase Decrease New since last portfolio | ||
Carmignac Portfolio Emerging Discovery A EUR Acc |